Letterlife

📍 Stockholm, Sweden🗓 Founded 2023👥 7 employees💰 Last funded Apr 2023
Mental Health Care🌐 letterlife.se?utm_source=linkedin-letterlife-page
Website LinkedIn
ADHD is a common and serious condition with a good prognosis if recognized early and treated adequately. Research shows that girls and women with ADHD, due to gender related social bias and biological differences receive their diagnosis several years later than boys and men. Research, health care and and peer support have lagged behind because of gender-specific challenges, and even though we know that female ADHD symptoms, and treatment effect change across the menstrual cycle, there is as of today the chance mitigate negative outcomes and improve quality of life for a substantial, clinically significant and vulnerable group and their relatives is wasted. Letterlife is developed with patients and clinicians, and internationally recognized experts in epidemiology, gynecology and female mental health supported by National Patient organizations for ADHD in Europe.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Finland
1
Sweden
1
Frequently asked questions
Who invested in Letterlife?
Letterlife has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Letterlife last raise funding?
The most recent investment in Letterlife recorded on gritt.io was in April 2023.
When was Letterlife founded?
Letterlife was founded in 2023.
What industry is Letterlife in?
Letterlife operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.
Where is Letterlife based?
Letterlife is headquartered in Stockholm, Sweden.